Dark Forest Capital Management’s Royalty Pharma RPRX Stock Holding History

Dark Forest Capital Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.38M	Sell	112,062 -166,251	-60%	-$7.28M	0.48%	35
2025 Q4	$10.8M	Buy	278,313 +53,681	+24%	+$2.05M	0.49%	10
2025 Q3	$7.93M	Buy	+224,632	New	+$8.13M	0.3%	41
2025 Q1	–	Sell	-134,116	Closed	-$3.42M	–	1408
2024 Q4	$3.42M	Sell	134,116 -10,362	-7%	-$275K	0.5%	18
2024 Q3	$4.09M	Sell	144,478 -194,197	-57%	-$5.38M	0.52%	26
2024 Q2	$8.93M	Buy	338,675 +327,659	+2,974%	+$9.08M	1.63%	5
2024 Q1	$335K	Buy	+11,016	New	+$325K	0.06%	427
2023 Q4	–	Sell	-66,710	Closed	-$1.81M	–	983
2023 Q3	$1.81M	Buy	66,710 +20,361	+44%	+$605K	0.14%	168
2023 Q2	$1.42M	Buy	+46,349	New	+$1.57M	0.13%	156
2023 Q1	–	Sell	-768	Closed	-$30.4K	–	1440
2022 Q4	$30.4K	Buy	+768	New	+$32.1K	0.01%	480
2022 Q3	–	Sell	-32	Closed	-$1K	–	1398
2022 Q2	$1K	Buy	+32	New	+$1.31K	﹤0.01%	817

Other funds holding RPRX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Dark Forest Capital Management's RPRX Position: Q1 2026 in Review

Dark Forest Capital Management reduced its Royalty Pharma (RPRX) stake by 60% in Q1 2026, selling an estimated $7.28M and leaving 112,062 shares worth $5.38M. The position accounts for 0.48% of the portfolio, ranked #35.

Dark Forest Capital Management first reported a position in RPRX in Q2 2022 and has held it in 11 quarters since. The position peaked at $10.8M in Q4 2025. 587 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

Dark Forest Capital Management held 112,062 shares of Royalty Pharma worth $5.38M as of Q1 2026.
Dark Forest Capital Management sold 166,251 Royalty Pharma shares in Q1 2026, an estimated $7.28M.
Royalty Pharma made up 0.48% of Dark Forest Capital Management's portfolio in Q1 2026, its #35 holding.
Dark Forest Capital Management first reported a position in Royalty Pharma in Q2 2022 and has held it in 11 quarters since.
Dark Forest Capital Management's Royalty Pharma position peaked at $10.8M in Q4 2025.
587 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.